Atea Pharmaceuticals Inc [NASDAQ: AVIR] jumped around 0.12 points on Thursday, while shares priced at $3.74 at the close of the session, up 3.17%.
Atea Pharmaceuticals Inc stock is now 10.98% up from its year-to-date (YTD) trading value. AVIR Stock saw the intraday high of $3.7599 and lowest of $3.65 per share. The company’s 52-week high price is 4.14, which means current price is +52.34% above from all time high which was touched on 07/02/25.
Compared to the average trading volume of 440.33K shares, AVIR reached a trading volume of 286948 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Atea Pharmaceuticals Inc [AVIR]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AVIR shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AVIR stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Morgan Stanley have made an estimate for Atea Pharmaceuticals Inc shares, keeping their opinion on the stock as Equal-Weight, with their previous recommendation back on August 13, 2024. The new note on the price target was released on August 10, 2023, representing the official price target for Atea Pharmaceuticals Inc stock. Previously, the target price had yet another drop from $14 to $7, while Morgan Stanley kept a Underweight rating on AVIR stock.
The Price to Book ratio for the last quarter was 0.78, with the Price to Cash per share for the same quarter was set at 4.97.
How has AVIR stock performed recently?
Atea Pharmaceuticals Inc [AVIR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.95. With this latest performance, AVIR shares gained by 16.15% in over the last four-week period, additionally plugging by 12.31% over the last 6 months – not to mention a rise of 11.64% in the past year of trading.
Atea Pharmaceuticals Inc [AVIR]: Deeper insight into the fundamentals
Return on Equity for this stock declined to -28.09%, with Return on Assets sitting at -28.09%.
Earnings analysis for Atea Pharmaceuticals Inc [AVIR]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AVIR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Atea Pharmaceuticals Inc go to 16.69%.
Insider trade positions for Atea Pharmaceuticals Inc [AVIR]
There are presently around $66.86%, or 75.80% of AVIR stock, in the hands of institutional investors. The top three institutional holders of AVIR stocks are: BLACKROCK INC. with ownership of 9.12 million shares, which is approximately 10.8251%. FMR LLC, holding 6.44 million shares of the stock with an approximate value of $$21.3 million in AVIR stocks shares; and FMR LLC, currently with $$21.1 million in AVIR stock with ownership which is approximately 7.5672%.
